Close Menu

NEW YORK – SpeeDx said on Monday it has agreed with Laboratory Corporation of America to codevelop diagnostic tests. The agreement focuses on assays for women's health and infectious diseases.

SpeeDx and LabCorp will work together to codevelop and introduce new molecular tests using SpeeDx's proprietary technology, the Australia-based firm said in an email. Financial terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.